RAC 1.38% $1.43 race oncology ltd

Nothing precludes Race running both a bisantrene + decitabine...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,808 Posts.
    lightbulb Created with Sketch. 10703
    Nothing precludes Race running both a bisantrene + decitabine and bisantrene + venetoclax AML trial. These combinations target different patient populations.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.43
Change
-0.020(1.38%)
Mkt cap ! $247.1M
Open High Low Value Volume
$1.45 $1.45 $1.43 $147 103

Buyers (Bids)

No. Vol. Price($)
3 14489 $1.39
 

Sellers (Offers)

Price($) Vol. No.
$1.43 1978 1
View Market Depth
Last trade - 10.30am 18/11/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.